Related Experiment Video

Updated: Jun 4, 2025

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

3.2K

Harnessing aryl hydrocarbon receptor dynamics: Unveiling therapeutic pathways in esophageal squamous cell carcinoma

Chun-Han Cheng1, Wen-Rui Hao2,3, Tzu-Hurng Cheng4

  • 1Department of Medical Education, Linkou Chang Gung Memorial Hospital, Taoyuan City 33305, Taiwan.

World Journal of Experimental Medicine
|December 23, 2024
PubMed

Insights

The aryl hydrocarbon receptor (AhR) plays a key role in esophageal squamous cell carcinoma development. Targeting AhR offers a promising therapeutic strategy for this cancer.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Esophageal squamous cell carcinoma (ESCC) is a significant global health concern.
  • The aryl hydrocarbon receptor (AhR) is increasingly recognized for its role in cancer development.
  • Understanding AhR's influence on the tumor microenvironment is crucial for therapeutic development.

Discussion:

  • Rahmati et al.'s minireview highlights the complex role of AhR in ESCC.
  • AhR modulation impacts immune cell function within the tumor microenvironment.
  • This review provides novel insights into AhR-targeted therapeutic strategies for ESCC.

Key Insights:

  • The aryl hydrocarbon receptor (AhR) is implicated in the pathogenesis of ESCC.
  • AhR signaling influences immune surveillance and evasion in the tumor microenvironment.
  • Targeting AhR presents a potential therapeutic avenue for ESCC treatment.

Outlook:

  • Further research into AhR pathways could uncover new biomarkers for ESCC.
  • Clinical investigations targeting AhR in ESCC are warranted.
  • This work sets the stage for developing novel immunotherapies and targeted treatments for ESCC.
Keywords:
Aryl hydrocarbon receptorEsophageal squamous cell carcinomaImmune modulationTherapeutic opportunitiesTumor microenvironment

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

377
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.0K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K